BELLEVUE, Wash.--(BUSINESS WIRE)--Radiant Research, a comprehensive clinical research company, today announced that it has completed a sale of the business to an ownership group led by ICICI Venture. Radiant will continue to provide development, study conduct, and centralized patient recruitment services to the biopharmaceutical, nutrition and medical device industry. “Our original venture capital investor group had been involved with Radiant since our inception in 1998. This change in ownership represents a natural transition from a start-up company to an established company with the financial resources to strategically advance all of our late phase service offerings,” said Pamela Spaniac, Chief Executive Officer of Radiant Research. “We are particularly excited about the potential for international expansion opportunities that ICICI Venture will provide.”
